Resource Library

See the outcomes of a large telecom company that executed responsible GLP-1 management and metabolic control through their partnership with Vida.

See the outcomes of a coordinated solution that pairs Vida’s personalized care with Judi® -driven medication management promoting behavior change and appropriate use of GLP-1s.

Across telecommunications, manufacturing, and financial services, employers are turning to Vida to address the dual challenge of rising GLP-1 costs and complex cardiometabolic conditions. This case study highlights three self-insured employers that partnered with Vida to tailor obesity care for their populations—with remarkable results.

Almost half of people with excess weight turn to GLP-1s as a first-line treatment, leading to less sustainable outcomes and rising healthcare costs. By partnering with Vida, we are improving access to obesity specialty care and helping organizations manage costs
and deliver better results.

Read our newest case study with Self-Insured Schools of California to learn how your people can also live a happier, healthier future with Vida.

Vida’s holistic care model and PBM relationships let us support high-value coverage strategies in ways others can’t. The proof is in the results: with our preferred prescriber program, only 9% of members started on GLP-1s — compared to 40–50% under unmanaged care. Want to see how one company reduced its GLP-1 impact with Vida?